Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Atai Life Sciences acquires exclusive rights to Psilera’s DMT patent portfolio Atai Life Sciences has taken a strategic step in expanding its position in psychedelic medicine by securing exclusive… byPallavi MadhirajuFebruary 22, 2025